Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)

Addiction Biology
Lucas R WattersonM Foster Olive


Reports of abuse and toxic effects of synthetic cathinones, frequently sold as 'bath salts' or 'legal highs', have increased dramatically in recent years. One of the most widely used synthetic cathinones is 3,4-methylenedioxypyrovalerone (MDPV). The current study evaluated the abuse potential of MDPV by assessing its ability to support intravenous self-administration and to lower thresholds for intracranial self-stimulation (ICSS) in rats. In the first experiment, the rats were trained to intravenously self-administer MDPV in daily 2-hour sessions for 10 days at doses of 0.05, 0.1 or 0.2 mg/kg per infusion. The rats were then allowed to self-administer MDPV under a progressive ratio (PR) schedule of reinforcement. Next, the rats self-administered MDPV for an additional 10 days under short access (ShA; 2 hours/day) or long access (LgA; 6 hours/day) conditions to assess escalation of intake. A separate group of rats underwent the same procedures, with the exception of self-administering methamphetamine (0.05 mg/kg per infusion) instead of MDPV. In the second experiment, the effects of MDPV on ICSS thresholds following acute administration (0.1, 0.5, 1 and 2 mg/kg, i.p.) were assessed. MDPV maintained self-administration across al...Continue Reading


Apr 1, 1978·Pharmacology, Biochemistry, and Behavior·R U EspositoC Kornetsky
Mar 1, 1979·Archives of General Psychiatry·C KornetskyJ O Jacobson
Jun 1, 1987·Pharmacology, Biochemistry, and Behavior·R A Meisch
Jan 1, 1973·International Pharmacopsychiatry·J GoldbergJ O Cole
Jan 1, 1984·Psychopharmacology·R J CollinsR R Russell
Jan 1, 1996·Annual Review of Neuroscience·R A Wise
Dec 1, 1954·Journal of Comparative and Physiological Psychology·J OLDS, P MILNER
Mar 23, 2006·Psychopharmacology·Osamu KitamuraLuigi Pulvirenti
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Justin T GassM Foster Olive
Dec 29, 2010·Toxicology Letters·I VardakouCh Spiliopoulou
Mar 17, 2011·Emergency Medicine Journal : EMJ·Mark Durham
Jul 15, 2011·Drug Testing and Analysis·John P Kelly
Aug 4, 2011·The Journal of Pharmacology and Experimental Therapeutics·Gregory C HadlockAnnette E Fleckenstein
Aug 10, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Henry A SpillerJoanne Jansen

❮ Previous
Next ❯


Jul 31, 2013·Forensic Science International : Synergy·Jolanta B Zawilska, Jakub Wojcieszak
Aug 6, 2013·Life Sciences·Christopher L GermanGlen R Hanson
Oct 18, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael H BaumannCharles W Schindler
Dec 6, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·William E FantegrossiKenner C Rice
Sep 29, 2015·Current Addiction Reports·Brenda M GannonWilliam E Fantegrossi
Dec 10, 2013·Archives of Toxicology·Maria João ValenteMárcia Carvalho
Oct 7, 2014·Pharmacology, Biochemistry, and Behavior·Heather E KingAnthony L Riley
Apr 18, 2014·Basic & Clinical Pharmacology & Toxicology·Louise KarlssonFredrik C Kugelberg
Jan 28, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Anna RickliMatthias E Liechti
Jun 22, 2014·Clinical Schizophrenia & Related Psychoses·Michelle E JohnDavid Hahn
Dec 4, 2014·Drug and Alcohol Dependence·Heather E KingAnthony L Riley
Feb 3, 2015·La Presse médicale·Laurent KarilaMichel Lejoyeux
Sep 5, 2014·Journal of Psychoactive Drugs·Marie Claire Van Hout
May 21, 2016·Thérapie·Anne BatisseUNKNOWN Réseau français des centres d’addictovigilance
Jun 10, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jacques D NguyenMichael A Taffe
Oct 21, 2014·Advances in Neuroscience·Lucas R Watterson, M Foster Olive
Aug 6, 2016·The Journal of Pharmacology and Experimental Therapeutics·Gregory T CollinsCharles P France
Aug 9, 2015·Journal of Psychopharmacology·Judith NovellasElena Escubedo
Aug 17, 2017·Journal of Psychoactive Drugs·Kirsten Elin SmithKevin Pangburn
Mar 22, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Luis M Colon-PerezMarcelo Febo
Dec 17, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kusumika SahaMichael H Baumann
Jul 31, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eugene A KiyatkinYavin Shaham
Dec 9, 2017·The Journal of Pharmacology and Experimental Therapeutics·Brenda M GannonGregory T Collins
Jun 22, 2017·Pharmacological Reviews·Paul T Bremer, Kim D Janda
Jun 29, 2014·Pharmacological Reviews·S Stevens Negus, Laurence L Miller

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.